Clinical trial
Randomized Trial to Assess Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization
NCT00165828 is registered in ClinicalTrials.gov with Eisai GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial to Assess Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization
- Lead sponsor
- Eisai GmbH
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- May 31, 2005
- Completion date
- February 29, 2008
- Enrollment
- 157 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.